Showing results (11-20 of 135) with videos related to
Sort By:
Pageof 14
Molecular Imaging and Biology|April 29, 2022
FDG PET/CT and Dosimetric Studies of 177Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma-Are We Hitting the Target?Ayca Løndalen, Johan Blakkisrud, Mona-Elisabeth Revheim, et al.Neurosurgery|November 11, 2024
Brain Abscess Causes Brain Damage With Long-Lasting Focal Cerebral Hypoactivity that Correlates With Abscess Size: A Cross-Sectional 18F-Fluoro-Deoxyglucose Positron Emission Tomography StudyEbba Gløersen Müller, Daniel Dahlberg, Bjørnar Hassel, et al.Acta Radiologica (Stockholm, Sweden : 1987)|March 7, 2013
An implementation of time-efficient respiratory-gated PET acquisition by repeated breath-holdsArne Skretting, Mona-Elisabeth Revheim, Ingerid Skjei Knudtsen, et al.Journal of Medical Case Reports|December 15, 2015
Translocational renal cell carcinoma (t(6;11)(p21;q12) with transcription factor EB (TFEB) amplification and an integrated precision approach: a case reportWolfgang Lilleby, Ljiljana Vlatkovic, Leonardo A Meza-Zepeda, et al.Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|December 7, 2017
18F-FDG PET/CT for the quantification of inflammation in large carotid artery plaquesKjersti Johnsrud, Karolina Skagen, Therese Seierstad, et al.PET Clinics|July 21, 2026
18F-Fluorodeoxyglucose PET, the Brain, and Other Organs: From the First Human Studies (1976) to 2026Abass Alavi, Mona-Elisabeth Revheim, Andrew B Newberg, et al.Frontiers in Medicine|February 3, 2023
Dual targeting with 224Ra/212Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approachAsta Juzeniene, Vilde Yuli Stenberg, Øyvind Sverre Bruland, et al.American Journal of Nuclear Medicine and Molecular Imaging|November 10, 2021
Critical review of PET imaging for detection and characterization of the atherosclerotic plaques with emphasis on limitations of FDG-PET compared to NaF-PET in this settingAbass Alavi, Thomas J Werner, William Raynor, et al.Diagnostics (Basel, Switzerland)|February 25, 2022
Clinical Applications of Somatostatin Receptor (Agonist) PET Tracers beyond Neuroendocrine TumorsRasmus Helgebostad, Mona-Elisabeth Revheim, Kjersti Johnsrud, et al.Journal of Alzheimer'S Disease : JAD|October 24, 2022
Amyloid PET: A Questionable Single Primary Surrogate Efficacy Measure on Alzheimer Immunotherapy TrialsPoul F Høilund-Carlsen, Mona-Elisabeth Revheim, Abass Alavi, et al.Pageof 14